EBV T-Cell Treatment for MS: Trial Update MStranslate July 13, 2022 Epstein-Barr virus, Progressive MS, Research, Treatments Research Update: ATA188 Phase 2 EMBOLD Study Today, Atara Biotherapeutics provided an update on their Phase 2 randomised clinical trial, called the...
EBV-Specific T Cell Therapy for Progressive MS MStranslate November 20, 2018 Epstein-Barr virus, Infection, Progressive MS, Research, Treatments Research Summary: Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis Last week, during our Facebook Live Q&A, we...
Natalizumab, B cells and Multiple Sclerosis MStranslate March 29, 2016 B Cells, Basic Sciences, Natalizumab, Research, Treatments Research Summary: Cutting Edge: Integrin a4 is required for regulatory B cell control of experimental autoimmune encephalomyelitis The...
Neuroprotection by Novel T Cell Enzyme Inhibitor MStranslate December 9, 2015 Research, Treatments Research Summary: Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo The background Previous studies have shown that...
Blood Protein Leakage Leads to Immune Response That Causes Nerve Damage in MS MStranslate December 16, 2012 Research What has been found? Part of the immune response that leads to damage of the nerves in neuroinflammatory disease is activated by the leakage of a...
